SCHEMBL985835

SCHEMBL985835

CCCCCCCCCc1cccc2c1Nc1ccccc1S2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX1 Q9Y5S8 11/20 0.49
GAA P10253 6/20 0.49
MAPT P10636 6/20 0.49
MEN1 O00255 4/20 0.49
KMT2A Q03164 4/20 0.49
ALOX15 P16050 3/20 0.49
TDP1 Q9NUW8 3/20 0.49
BCHE P06276 2/20 0.49
ACHE P22303 2/20 0.49
SNCA P37840 2/20 0.49
CYP1A2 P05177 1/20 0.49
POLB P06746 1/20 0.49
CYP3A4 P08684 1/20 0.49
ADORA3 P0DMS8 1/20 0.49
ALOX12 P18054 1/20 0.49
MAOA P21397 1/20 0.49
CNR1 P21554 1/20 0.49
PTGS1 P23219 1/20 0.49
SLC6A2 P23975 1/20 0.49
HTR2C P28335 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30957954 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL30957960 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL30957964 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL30957962 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL31441075 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL252565 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL17453909 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL985674 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL986417 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A
SCHEMBL6118755 1.00 NOX1 (0.49) NOX1GAAMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396271-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF Momentive Performance Materials Inc. (US) 2024-07-10 EP claimed
WO-2023034354-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. (US) 2023-03-09 WO claimed
WO-2020117461-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2020-06-11 WO claimed
US-20190169519-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2019-06-06 US claimed
EP-3320061-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME ExxonMobil Research and Engineering Company (US) 2018-05-16 EP claimed
WO-2017007706-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2017-01-12 WO claimed
US-20170009174-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2017-01-12 US claimed
US-7897311-B2 Phenothiazine containing photogenerating layer photoconductors XEROX CORPORATION (US) 2011-03-01 US claimed
US-20090274969-A1 PHENOTHIAZINE CONTAINING PHOTOGENERATING LAYER PHOTOCONDUCTORS XEROX CORPORATION (US) 2009-11-05 US claimed
US-20050090407-A1 Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine ETHYL CORPORATION (US) 2005-04-28 US claimed
US-20050085398-A1 Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine ETHYL CORPORATION (US) 2005-04-21 US claimed
EP-1369469-B1 An antioxidant additives combination for lubricants containing a molybdenum complex and an alkylated phenothiazine ETHYL CORP (US) 2005-03-09 EP claimed
US-6797677-B2 PARTICULARLY SUITED FOR USE AS A CRANKCASE LUBRICANT, OR A TRANSMISSION LUBRICANT, INCLUDING LOW LEVELS AND ZERO LEVELS OF PHOSPHORUS. AFTON CHEMICAL CORPORATION 2004-09-28 US claimed
EP-1369469-A1 An antioxidant additives combination for lubricants containing a molybdenum complex and an alkylated phenothiazine ETHYL CORPORATION (US) 2003-12-10 EP claimed
US-20030224950-A1 Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine AFTON CHEMICAL CORPORATION 2003-12-04 US claimed
US-6599865-B1 Lubricating oil, and a minor amount of an oil soluble alkylated diarylamine, an oil soluble alkylated phenothiazine, and an oil soluble sulfurized compound, said sulfurized compound selected from sulfurized olefins and fatty oils ETHYL CORPORATION 2003-07-29 US claimed
WO-2025133763-A1 RETROREFLECTIVE ARTICLE INCLUDING A RETROREFLECTIVE LAYER AND A LIGHT DOWN CONVERSION MATERIAL, KITS, AND METHODS THEREOF 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-06-26 WO disclosed
US-20240400793-A1 COMPOSITION FOR POLYURETHANE FOAM, FOAM PREPARED THEREFROM AND A METHOD THEREOF MOMENTIVE PERFORMANCE MATERIALS INC. 2024-12-05 US disclosed
WO-2005040289-A1 REINFORCED COATINGS WITH IMPROVED SCRATCH RESISTANCE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-05-06 WO disclosed
US-6599865-B1 Lubricating oil, and a minor amount of an oil soluble alkylated diarylamine, an oil soluble alkylated phenothiazine, and an oil soluble sulfurized compound, said sulfurized compound selected from sulfurized olefins and fatty oils ETHYL CORPORATION 2003-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169519-A1 MULTIFUNCTIONAL LUBRICATING OIL BASE STOCKS AND PROCESSES FOR PREPARING SAME DEGS1, SAMM50, F12 NOX1 524/4885GAA 4540/4885MAPT 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.